Claus Christiansen is the founder of Nordic Bioscience and the Danish Research Foundation. He earned his medical degree in 1971 from University of Copenhagen – the same year that he published his first peer-reviewed paper. His work has changed the field of osteoporosis and he has been instrumental in creating a scientific cross-disciplinary environment for PhDs with an interest in the life science industry. His research is published in high-ranking journals, and has an H factor above 140. With a long scientific background in bone diseases, Dr. Claus Christiansen cofounded Osteometer A/S in 1989, a company that developed and manufactured medical devices for measuring bone mineral density. In 1991, the company expanded to include a laboratory division for the development of biochemical markers, which later became Nordic Bioscience A/S, and has grown to be a partner to some of the largest drug developers in the world.

Rocco Arcidiacono brings expertise in corporate governance and certified board membership to Key Bioscience. With a background in business administration, Rocco has held significant leadership roles, including Partner and Director at Fiduciaria Mega SA in Lugano. His extensive experience in managing reorganization and business transfer projects, both nationally and internationally, underscores his proficiency in navigating complex corporate matters. Rocco’s commitment to life sciences extends beyond Key Bioscience, as he also serves as a board member for the life science company, Sintetica. His affiliations with organizations such as EXPERTsuisse and IFA further demonstrate his dedication to professional standards and industry best practices in the biotech sector.